Literature DB >> 21592494

Pharmacokinetics of levetiracetam in neonates with seizures.

Stephanie L Merhar1, Kurt R Schibler, Catherine M Sherwin, Jareen Meinzen-Derr, Jing Shi, Tonya Balmakund, Alexander A Vinks.   

Abstract

The pharmacokinetics of levetiracetam were determined prospectively in 18 neonates with seizures. Neonates were found to have lower clearance, higher volume of distribution, and a longer half-life as compared with older children and adults. Mild somnolence was the only adverse effect.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592494      PMCID: PMC3789844          DOI: 10.1016/j.jpeds.2011.03.057

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Levetiracetam: safety and efficacy in neonatal seizures.

Authors:  Georgia Ramantani; Chrysanthy Ikonomidou; Beate Walter; Dietz Rating; Juergen Dinger
Journal:  Eur J Paediatr Neurol       Date:  2010-11-19       Impact factor: 3.140

2.  Antiepileptic drugs and apoptotic neurodegeneration in the developing brain.

Authors:  Petra Bittigau; Marco Sifringer; Kerstin Genz; Ellen Reith; Dana Pospischil; Suresh Govindarajalu; Mark Dzietko; Stefanie Pesditschek; Ingrid Mai; Krikor Dikranian; John W Olney; Chrysanthy Ikonomidou
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

3.  Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Tiedong Guo; Lisa M Oswald; Damodara Rao Mendu; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2006-06-27       Impact factor: 3.786

4.  Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence.

Authors:  J R Farwell; Y J Lee; D G Hirtz; S I Sulzbacher; J H Ellenberg; K B Nelson
Journal:  N Engl J Med       Date:  1990-02-08       Impact factor: 91.245

5.  Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.

Authors:  S Grosso; E Franzoni; G Coppola; P Iannetti; A Verrotti; D M Cordelli; V Marchiani; A Pascotto; A Spalice; B Acampora; G Morgese; P Balestri
Journal:  Seizure       Date:  2005-06       Impact factor: 3.184

6.  Pharmacokinetic study of levetiracetam in children.

Authors:  J M Pellock; T A Glauser; E M Bebin; N B Fountain; F J Ritter; R M Coupez; W D Shields
Journal:  Epilepsia       Date:  2001-12       Impact factor: 5.864

7.  Efficacy and safety of levetiracetam in infants and young children with refractory epilepsy.

Authors:  S Grosso; D M Cordelli; E Franzoni; G Coppola; G Capovilla; N Zamponi; A Verrotti; G Morgese; P Balestri
Journal:  Seizure       Date:  2007-03-26       Impact factor: 3.184

Review 8.  Clinical pharmacokinetics of levetiracetam.

Authors:  Philip N Patsalos
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Pharmacokinetics of levetiracetam in infants and young children with epilepsy.

Authors:  Tracy A Glauser; Wendy G Mitchell; Arie Weinstock; Martina Bebin; Dion Chen; Rene Coupez; Armel Stockis; Zhihong Sarah Lu
Journal:  Epilepsia       Date:  2007-04-18       Impact factor: 5.864

10.  Levetiracetam for the treatment of neonatal seizures.

Authors:  Michael T Shoemaker; Joshua S Rotenberg
Journal:  J Child Neurol       Date:  2007-01       Impact factor: 1.987

View more
  25 in total

Review 1.  Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy.

Authors:  Elissa Yozawitz; Arthur Stacey; Ronit M Pressler
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

2.  Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.

Authors:  Ying-hui Wang; Li Wang; Wei Lu; De-wei Shang; Min-ji Wei; Ye Wu
Journal:  Acta Pharmacol Sin       Date:  2012-06       Impact factor: 6.150

Review 3.  Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.

Authors:  Maria D Donovan; Geraldine B Boylan; Deirdre M Murray; John F Cryan; Brendan T Griffin
Journal:  Br J Clin Pharmacol       Date:  2015-11-04       Impact factor: 4.335

4.  Response of levetiracetam in neonatal seizures.

Authors:  Maggie Lo-Yee Yau; Eva Lai-Wah Fung; Pak Cheung Ng
Journal:  World J Clin Pediatr       Date:  2015-08-08

5.  Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial.

Authors:  Cynthia Sharpe; Gail E Reiner; Suzanne L Davis; Mark Nespeca; Jeffrey J Gold; Maynard Rasmussen; Rachel Kuperman; Mary Jo Harbert; David Michelson; Priscilla Joe; Sonya Wang; Neggy Rismanchi; Ngoc Minh Le; Andrew Mower; Jae Kim; Malcolm R Battin; Brian Lane; Jose Honold; Ellen Knodel; Kathy Arnell; Renee Bridge; Lilly Lee; Karin Ernstrom; Rema Raman; Richard H Haas
Journal:  Pediatrics       Date:  2020-05-08       Impact factor: 7.124

Review 6.  Levetiracetam in neonatal seizures: a review.

Authors:  Allison L Mruk; Karen L Garlitz; Noelle R Leung
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

7.  Response to antiseizure medications in neonates with acute symptomatic seizures.

Authors:  Hannah C Glass; Janet S Soul; Catherine J Chu; Shavonne L Massey; Courtney J Wusthoff; Taeun Chang; Maria Roberta Cilio; Sonia L Bonifacio; Nicholas S Abend; Cameron Thomas; Monica Lemmon; Charles E McCulloch; Renée A Shellhaas
Journal:  Epilepsia       Date:  2019-02-20       Impact factor: 5.864

Review 8.  Neonatal seizures: advances in mechanisms and management.

Authors:  Hannah C Glass
Journal:  Clin Perinatol       Date:  2013-12-12       Impact factor: 3.430

Review 9.  Clinical management of seizures in newborns : diagnosis and treatment.

Authors:  Linda G M van Rooij; Marcel P H van den Broek; Carin M A Rademaker; Linda S de Vries
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

Review 10.  Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.

Authors:  Maria D Donovan; Brendan T Griffin; Liudmila Kharoshankaya; John F Cryan; Geraldine B Boylan
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.